Co-Authors
This is a "connection" page, showing publications co-authored by Xuan Dong and SiSi Huang.
Connection Strength
0.232
-
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study. Front Immunol. 2021; 12:673693.
Score: 0.060
-
Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients. BMC Infect Dis. 2021 Apr 29; 21(1):398.
Score: 0.059
-
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J Clin Invest. 2020 12 01; 130(12):6417-6428.
Score: 0.057
-
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensive Care. 2020 Jul 31; 10(1):99.
Score: 0.056